Tae‐You Kim

Brigham and Women's Hospital ORCID: 0000-0002-9986-2684

3

h-index

3

Publications

6,871

Citations

Publications

3 shown

Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein

Michael Ohh , Cheol Won Park , Mircea Ivan +6 more

2000 Nature Cell Biology 1574 citations

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry , Bruno Sangro , Thomas Yau +18 more

2017 The Lancet 4168 citations

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau , Yoon‐Koo Kang , Tae‐You Kim +18 more

ClinicalTrials.gov Identifier: NCT01658878.

2020 JAMA Oncology 1129 citations

Frequent Co-Authors

Michael Ohh

Brigham and Women's Hospital

Cheol Won Park

Harvard University

Mircea Ivan

Brigham and Women's Hospital

Michael A. Hoffman

Brigham and Women's Hospital

Eric Huang

Brigham and Women's Hospital

Nikola P. Pavletich

Memorial Sloan Kettering Cancer Center

Researcher Info

h-index: 3
Publications: 3
Citations: 6,871
Institution: Brigham and Women's Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9986-2684

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.

Academic Output Over Time